Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Lung & Bronchus (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 37.5 (37.4, 37.6) N/A 149,248 66.9
Puerto Rico 6 7.9 (7.5, 8.3) N/A 344 49.6
Utah 3 18.3 (17.6, 19.1) 50 (50, 50) 496 70.6
New Mexico 3 21.5 (20.7, 22.3) 49 (49, 49) 586 60.4
Colorado 6 25.5 (24.9, 26.1) 48 (46, 48) 1,570 65.2
Arizona 6 26.5 (26.0, 26.9) 47 (44, 48) 2,435 60.7
Wyoming 6 26.5 (24.8, 28.3) 46 (44, 48) 191 63.6
California 3 26.8 (26.5, 27.0) 45 (44, 47) 11,627 68.3
District of Columbia 6 27.2 (25.4, 29.0) 44 (44, 48) 185 61.8
Texas 3 31.1 (30.8, 31.4) 43 (42, 43) 8,847 65.2
Hawaii 3 31.8 (30.6, 33.0) 42 (38, 43) 607 73.0
Montana 6 32.9 (31.5, 34.2) 41 (36, 43) 482 66.1
Oregon 6 32.9 (32.2, 33.6) 40 (38, 42) 1,788 64.5
Idaho 3 33.0 (31.8, 34.1) 39 (37, 42) 672 68.9
Washington 5 33.3 (32.7, 33.8) 38 (37, 41) 2,932 65.2
Minnesota 6 34.5 (33.8, 35.1) 37 (34, 38) 2,362 62.5
Maryland 6 34.8 (34.2, 35.5) 36 (33, 38) 2,546 65.0
New Jersey 3 35.3 (34.8, 35.8) 35 (32, 37) 3,957 66.2
Nebraska 6 35.5 (34.4, 36.6) 34 (30, 37) 819 64.9
Virginia 6 35.8 (35.2, 36.3) 33 (31, 36) 3,669 67.1
Alaska 6 36.5 (34.4, 38.7) 32 (24, 38) 257 68.9
Florida 6 36.7 (36.4, 37.0) 31 (28, 33) 11,474 65.0
Kansas 6 37.2 (36.3, 38.2) 30 (25, 33) 1,318 68.4
New York 3 37.3 (37.0, 37.7) 29 (25, 31) 9,232 64.9
Connecticut 3 37.3 (36.6, 38.1) 28 (25, 32) 1,779 65.3
Massachusetts 3 37.4 (36.8, 38.0) 27 (25, 32) 3,275 62.4
South Dakota 6 38.1 (36.5, 39.9) 26 (21, 33) 419 68.2
North Dakota 6 38.6 (36.8, 40.6) 25 (19, 32) 339 68.0
Alabama 6 39.5 (38.9, 40.3) 24 (21, 26) 2,533 63.6
Vermont 6 39.9 (38.1, 41.9) 23 (14, 29) 359 68.2
South Carolina 6 40.1 (39.4, 40.8) 22 (19, 25) 2,707 65.9
Wisconsin 6 40.5 (39.9, 41.2) 21 (18, 24) 3,067 69.4
Delaware 6 41.0 (39.5, 42.7) 20 (13, 25) 549 66.5
Illinois 3 41.3 (40.9, 41.8) 19 (16, 21) 6,399 67.7
Pennsylvania 6 41.4 (41.0, 41.9) 18 (16, 21) 7,332 67.2
New Hampshire 6 42.0 (40.7, 43.4) 17 (13, 23) 791 67.7
Michigan 6 42.1 (41.6, 42.6) 16 (13, 19) 5,552 68.6
Oklahoma 6 42.5 (41.7, 43.4) 15 (13, 19) 2,038 65.0
Georgia 3 42.5 (42.0, 43.1) 14 (13, 18) 4,947 71.9
Rhode Island 6 43.6 (42.1, 45.3) 13 (9, 18) 609 64.2
Ohio 6 44.8 (44.4, 45.3) 12 (9, 13) 6,843 67.4
North Carolina 6 44.9 (44.4, 45.4) 11 (9, 13) 5,791 69.4
Iowa 3 45.1 (44.1, 46.0) 10 (8, 13) 1,835 72.3
Missouri 6 46.1 (45.4, 46.8) 9 (8, 10) 3,656 66.3
Louisiana 3 46.2 (45.4, 47.0) 8 (7, 11) 2,606 73.3
Indiana 6 48.4 (47.7, 49.1) 7 (4, 7) 3,944 70.1
Maine 6 48.4 (47.1, 49.9) 6 (4, 8) 987 68.9
Tennessee 6 48.6 (47.9, 49.2) 5 (4, 7) 4,159 66.9
Arkansas 6 49.6 (48.6, 50.6) 4 (3, 7) 1,930 65.9
Mississippi 6 51.1 (50.0, 52.2) 3 (3, 4) 1,885 70.4
West Virginia 6 55.1 (53.8, 56.4) 2 (2, 2) 1,474 70.6
Kentucky 3 61.9 (61.0, 62.8) 1 (1, 1) 3,509 71.3
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 11/27/2022 4:39 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
3 Source: SEER November 2021 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2021 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top